Acasti Pharma reported CAD119.8M in Assets for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Assets Change
Acasti Pharma ACST:US C$ 119.8M 57.34M
Addus Homecare ADUS:US $ 924.92M 35.76M
Agile Therapeutics AGRX:US $ 36.68M 15.6M
Amarin AMRN:US $ 1035.8M 9.19M
Bioscrip BIOS:US $ 2786.14M 67.39M
Genetic Technologies GENE:US $ 22.97M 4.13M
Pain Therapeutics PTIE:US $ 274.25M 7.06M